Indication
Edarbi is indicated for the treatment of essential hypertension in adults.
Loading your page…
Loading your page…
Hypertension
Marketing Authorisation Holder: Takeda Pharma A/S
EMA Authorisation: 07/12/2011
INN: azilsartan medoxomil
AI Drug & Interaction Analysis
Free account required
Ask Osler about Edarbi: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.